Embed Size (px)
Citation preview
A
B
Fig. 1, AbdelHafez et al.
untreated
Conc 1
Conc 2
Conc 1: 0.0325 mg/kg/day Conc 2: 0.065 mg/kg/day
A
Fig. 2, AbdelHafez et al.
Conc 1 Conc 2
control
0 1 2 3 4 5 6 7 8 90
500
1000
1500
2000Control1mg/kg/day5mg/kg/day
Weeks
Tum
or v
olum
e (m
m^3
)
0 1 2 3 4 5 6 7 8 915.0
17.5
20.0
22.5
25.0
27.5
30.0
32.5Control1mg/kg/day5mg/kg/day
Weeks
Mou
se w
eigh
t (g
)
B
C
Fig. 2, AbdelHafez et al.
Control
0.0325mg/kg/day 0.065mg/kg/day
Control
0.0325mg/kg/day 0.065mg/kg/day
Fig. 3, AbdelHafez et al.
Fig. 4, AbdelHafez et al.
Fig. 5, AbdelHafez et al.
SA-‐I-‐12
% Cell V
iability
uM
SA-‐I-‐03
% Cell V
iability
uM
SA-‐I-‐13
% Cell V
iability
uM
SA-‐I-‐15
% Cell V
iability
uM
A
Fig. 6, AbdelHafez et al.
D C
B
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐12 H-‐12
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐3 H-‐3
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐13 H-‐13
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐15 H-‐15
SA-‐I-‐16
% Cell V
iability
uM
SA-‐I-‐20
% Cell V
iability
uM
E
Fig. 6, AbdelHafez et al.
G
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐16 H-‐16
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐20 H-‐20
SA-‐I-‐19
% Cell V
iability
uM
F
SA-‐I-‐21
% Cell V
iability
uM
H
0
20
40
60
80
100
120
0 10 20 40 80 160
H-‐19 H2-‐19
0
50
100
150
0 10 20 40 80 160
H2-‐21 H-‐21
SA-‐I-‐29
% Cell V
iability
uM
SA-‐I-‐39
% Cell V
iability
uM
K
J
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐29 H-‐29
0
20
40
60
80
100
120
0 40 80 120 160 200
H2-‐39 H-‐39
SA-‐I-‐58
% Cell V
iability
uM
SA-‐I-‐27 % Cell V
iability
uM
I
0
20
40
60
80
100
120
0 10 20 40 80 160
H-‐27 H2-‐27
0
50
100
150
0 10 20 40 80 160
H-‐58 H2-‐58
L
Fig. 5, AbdelHafez et al.
Fig. 7, AbdelHafez et al.
